ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AGN Argenica Therapeutics Limited

0.80
0.03 (3.90%)
Last Updated: 02:06:03
Delayed by 20 minutes

Argenica Therapeutics Financial Summary

The current AGN market cap is 98.25M. The company's latest EPS is AUD -0.0446 and P/E is -17.94.

Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 0296k259k1.75M2.6M
Operating Income 0-614k-4.09M-4.88M-5.67M
Net Income 0-1.03M-4.09M-4.82M-5.48M
Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 7.52M7.27M9.04M9.54M16.38M
Total Liabilities 58k426k736k1.87M2.43M
Total Equity 7.46M6.85M8.31M7.67M13.95M

Cash Flow

Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating N/A -1.05M-3.36M-3.3M-5.06M
Investing N/A N/A N/A -50k50k
Financing N/A 7.85M5.13M3.73M11.64M
Market Cap 98.25M
Price to Earnings Ratio -17.94
Price to Sales Ratio 37.74
Price to Cash Ratio 6.17
Price to Book Ratio 7.04
Dividend Yield -

Share Statistics

Shares Outstanding 122.82M
Average Volume (1 week) 85.63k
Average Volume (1 Month) 133.93k
52 Week Change 33.33%
52 Week High 0.985
52 Week Low 0.535
Spread (Intraday) 0.03 (3.21%)

Company Info

Company Name Argenica Therapeutics Limited
Address unit 4
nedlands, western australia 6009
Website https://
Industry pharmaceutical preparations (2834)